Caricamento...
Review of Bone Modifying Agents in Metastatic Breast Cancer
Bone is the most common site for distant metastases in breast cancer and can cause significant morbidity and mortality. Bone modifying agents (BMAs) that include bisphosphonates (BPAs) and denosumab help in decreasing and delaying skeletal-related events (SREs) associated with metastatic breast canc...
Salvato in:
| Pubblicato in: | Cureus |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Cureus
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7960030/ https://ncbi.nlm.nih.gov/pubmed/33738175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13332 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|